Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (146)

2023

  1. Quantitative PET tracking of intra-articularly administered 89Zr-peptide-decorated nanoemulsions

    Journal of Controlled Release, Vol. 356, pp. 702-713

2022

  1. 18F-florbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 49, Núm. 4, pp. 1242-1253

  2. Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence

    Pharmaceutics, Vol. 14, Núm. 10

  3. Development of an ultra-thin parallel plate ionization chamber for dosimetry in FLASH radiotherapy

    Medical Physics, Vol. 49, Núm. 7, pp. 4705-4714

  4. Immunohistochemical expression of VEGFR1 in non small cell lung carcinomas: Lower VEGFR1 expression is asociated with squamous cell carcinoma subtype and high max SUV values in 18F-FDG PET

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 41, Núm. 1, pp. 28-31

  5. Numerical modeling of air-vented parallel plate ionization chambers for ultra-high dose rate applications

    Physica Medica, Vol. 103, pp. 147-156

  6. PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model

    International Journal of Pharmaceutics, Vol. 627

2021

  1. A systematic review of pet textural analysis and radiomics in cancer

    Diagnostics, Vol. 11, Núm. 2

  2. Anti-inflammatory effect of tacrolimus/hydroxypropyl-β-cyclodextrin eye drops in an endotoxin-induced uveitis model

    Pharmaceutics, Vol. 13, Núm. 10

  3. Correction to: Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer? (European Radiology, (2021), 31, 6, (4156-4165), 10.1007/s00330-020-07507-z)

    European Radiology

  4. Development and characterization of a tacrolimus/ hydroxypropyl-β-cyclodextrin eye drop

    Pharmaceutics, Vol. 13, Núm. 2, pp. 1-27

  5. Development and characterization of inhaled ethanol as a novel pharmacological strategy currently evaluated in a phase ii clinical trial for early-stage sars-cov-2 infection

    Pharmaceutics, Vol. 13, Núm. 3

  6. Evaluation of indirect damage and damage saturation effects in dose–response curves of hypofractionated radiotherapy of early-stage NSCLC and brain metastases

    Radiotherapy and Oncology, Vol. 161, pp. 1-8

  7. Feasibility of Longitudinal Brain PET with Real-Time Arterial Input Function in Rats

    Molecular Imaging and Biology, Vol. 23, Núm. 3, pp. 350-360

  8. In situ forming and mucoadhesive ophthalmic voriconazole/HPβCD hydrogels for the treatment of fungal keratitis

    International Journal of Pharmaceutics, Vol. 597

  9. Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer?

    European Radiology, Vol. 31, Núm. 6, pp. 4156-4165

  10. Online recombination correction in dosimetry with arrays of ionization chambers: Application to FFF and UHDR radiotherapy

    Applied Sciences (Switzerland), Vol. 11, Núm. 21

  11. Quantification of internal dosimetry in PET patients II: Individualized Monte Carlo-based dosimetry for [18F]fluorocholine PET

    Medical Physics, Vol. 48, Núm. 9, pp. 5448-5458

2020

  1. -FMISO PET/MRI Imaging Shows Ischemic Tissue around Hematoma in Intracerebral Hemorrhage

    Molecular Pharmaceutics, Vol. 17, Núm. 12, pp. 4667-4675

  2. 3D printed tacrolimus rectal formulations ameliorate colitis in an experimental animal model of inflammatory bowel disease

    Biomedicines, Vol. 8, Núm. 12, pp. 1-19